Cardiac inotropic actions of urocortin in conscious sheep

被引:162
作者
Parkes, DG
Vaughan, J
Rivier, J
Vale, W
May, CN
机构
[1] UNIV MELBOURNE, HOWARD FLOREY INST EXPT PHYSIOL & MED, PARKVILLE, VIC 3052, AUSTRALIA
[2] SALK INST BIOL STUDIES, PEPTIDE BIOL LABS, LA JOLLA, CA 92161 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 1997年 / 272卷 / 05期
关键词
corticotropin-releasing factor; blood pressure; cardiac contractility; adrenocorticotropin;
D O I
10.1152/ajpheart.1997.272.5.H2115
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Urocortin (Ucn) is a recently isolated peptide related to the corticotropin-releasing factor (CRF) family, which can produce hemodynamic and hormonal actions in conscious rats. This study examined in detail the cardiovascular actions of Ucn and CRF after intravenous injection in chronically instrumented, conscious sheep. Injection of Ucn produced dose-dependent changes in cardiac contractility [rate of increase of aortic flow (dF/dt)], maximum aortic flow (F-max), mean arterial pressure (MAP), heart rate (HR), cardiac output (CO), and coronary blood flow (CF). Ucn injected at 100 mu g produced a potent increase in dF/dt, from 909 +/- 44 to a maximum of 1,849 +/- 901.min(-1).s(-1), and in F-max, from 25.5 +/- 0.8 to 36.6 +/- 1.4 l/min. Cardiac contractility increased within 30 min of injection and remained significantly elevated for up to 24 h. MAP increased from 78 +/- 2 to 90 +/- 3 mmHg, and HR increased from 73 +/- 4 to 103 +/- 9 beats/min. CO rose from 5.0 +/- 0.1 to 5.8 +/- 0.2 l/min, whereas central venous pressure, total peripheral conductance, and stroke volume were unchanged. All Ucn-induced cardiovascular effects were inhibited by prior treatment with the CRF antagonist a-helical CRF-(9-41). Equimolar doses of CRF produced little change in any hemodynamic parameter. Both peptides increased plasma levels of adrenocorticotropin and cortisol, with Ucn having a more potent effect than CRF. We have shown for the first time that Ucn can produce potent and long-lasting actions to elevate cardiac contractility in conscious animals.
引用
收藏
页码:H2115 / H2122
页数:8
相关论文
共 38 条
[1]   DIFFERENTIAL REGIONAL HEMODYNAMIC-EFFECTS OF CORTICOTROPIN IN CONSCIOUS SHEEP [J].
BEDNARIK, JA ;
MAY, CN .
HYPERTENSION, 1994, 24 (01) :49-55
[2]   EVALUATION OF A TRANSIT-TIME SYSTEM FOR THE CHRONIC MEASUREMENT OF BLOOD-FLOW IN CONSCIOUS SHEEP [J].
BEDNARIK, JA ;
MAY, CN .
JOURNAL OF APPLIED PHYSIOLOGY, 1995, 78 (02) :524-530
[3]   CENTRAL NERVOUS-SYSTEM EFFECTS OF CORTICOTROPIN RELEASING-FACTOR IN THE DOG [J].
BROWN, MR ;
FISHER, LA .
BRAIN RESEARCH, 1983, 280 (01) :75-79
[4]  
CHADWICK D, 1993, CORTICOTROPIN RELEAS
[5]   Cloning and characterization of human urocortin [J].
Donaldson, CJ ;
Sutton, SW ;
Perrin, MH ;
Corrigan, AZ ;
Lewis, KA ;
Rivier, JE ;
Vaughan, JM ;
Vale, WW .
ENDOCRINOLOGY, 1996, 137 (05) :2167-2170
[6]   [DES-ASP1]ANGIOTENSIN-II IN THE SHEEP - BLOOD-LEVELS AND ITS EFFECT ON PLASMA-RENIN CONCENTRATION [J].
FEI, DTW ;
GRAHAM, WF ;
MCDOUGAL, JG ;
SCOGGINS, BA ;
COGHLAN, JP .
LIFE SCIENCES, 1980, 27 (16) :1495-1502
[7]   DIFFERENTIAL ANTAGONIST ACTIVITY OF ALPHA-HELICAL CORTICOTROPIN-RELEASING-FACTOR9-41 IN 3 BIOASSAY SYSTEMS [J].
FISHER, L ;
RIVIER, C ;
RIVIER, J ;
BROWN, M .
ENDOCRINOLOGY, 1991, 129 (03) :1312-1316
[8]   CORTICOTROPIN-RELEASING FACTOR AND ANGIOTENSIN-II - COMPARISON OF CNS ACTIONS TO INFLUENCE NEUROENDOCRINE AND CARDIOVASCULAR FUNCTION [J].
FISHER, LA ;
BROWN, MR .
BRAIN RESEARCH, 1984, 296 (01) :41-47
[9]   REGIONAL HEMODYNAMIC-RESPONSES TO CENTRAL ADMINISTRATION OF CORTICOTROPIN-RELEASING FACTOR (CRF) [J].
GROSSKREUTZ, CL ;
BRODY, MJ .
BRAIN RESEARCH, 1988, 442 (02) :363-367
[10]   EFFECTS OF CORTICOTROPIN-RELEASING FACTOR ON ISOLATED RAT-HEART ACTIVITY [J].
GRUNT, M ;
GLASER, J ;
SCHMIDHUBER, H ;
PAUSCHINGER, P ;
BORN, J .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (04) :H1124-H1129